FDA clears Qiagen bloodstream infection panel for U.S. market
Go back to FDA clears Qiagen bloodstream infection panel for U.S. market| Qiagen NV (NYSE: QGEN) | Delayed: 43.70 -0.68 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.38 | 52 Week High | $28.50 | |||
| Open | $44.30 | 52 Week Low | $19.94 | |||
| Day High | $44.36 | P/E | 150.69 | |||
| Day Low | $43.57 | EPS | $0.29 | |||
| Volume | 688,545 | |||||
